Cargando…
Novel Trypanocidal Inhibitors that Block Glycosome Biogenesis by Targeting PEX3–PEX19 Interaction
Human pathogenic trypanosomatid parasites harbor a unique form of peroxisomes termed glycosomes that are essential for parasite viability. We and others previously identified and characterized the essential Trypanosoma brucei ortholog TbPEX3, which is the membrane-docking factor for the cytosolic re...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721105/ https://www.ncbi.nlm.nih.gov/pubmed/34988071 http://dx.doi.org/10.3389/fcell.2021.737159 |
_version_ | 1784625264069705728 |
---|---|
author | Li, Mengqiao Gaussmann, Stefan Tippler, Bettina Ott, Julia Popowicz, Grzegorz M Schliebs, Wolfgang Sattler, Michael Erdmann, Ralf Kalel, Vishal C |
author_facet | Li, Mengqiao Gaussmann, Stefan Tippler, Bettina Ott, Julia Popowicz, Grzegorz M Schliebs, Wolfgang Sattler, Michael Erdmann, Ralf Kalel, Vishal C |
author_sort | Li, Mengqiao |
collection | PubMed |
description | Human pathogenic trypanosomatid parasites harbor a unique form of peroxisomes termed glycosomes that are essential for parasite viability. We and others previously identified and characterized the essential Trypanosoma brucei ortholog TbPEX3, which is the membrane-docking factor for the cytosolic receptor PEX19 bound to the glycosomal membrane proteins. Knockdown of TbPEX3 expression leads to mislocalization of glycosomal membrane and matrix proteins, and subsequent cell death. As an early step in glycosome biogenesis, the PEX3–PEX19 interaction is an attractive drug target. We established a high-throughput assay for TbPEX3–TbPEX19 interaction and screened a compound library for small-molecule inhibitors. Hits from the screen were further validated using an in vitro ELISA assay. We identified three compounds, which exhibit significant trypanocidal activity but show no apparent toxicity to human cells. Furthermore, we show that these compounds lead to mislocalization of glycosomal proteins, which is toxic to the trypanosomes. Moreover, NMR-based experiments indicate that the inhibitors bind to PEX3. The inhibitors interfering with glycosomal biogenesis by targeting the TbPEX3–TbPEX19 interaction serve as starting points for further optimization and anti-trypanosomal drug development. |
format | Online Article Text |
id | pubmed-8721105 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87211052022-01-04 Novel Trypanocidal Inhibitors that Block Glycosome Biogenesis by Targeting PEX3–PEX19 Interaction Li, Mengqiao Gaussmann, Stefan Tippler, Bettina Ott, Julia Popowicz, Grzegorz M Schliebs, Wolfgang Sattler, Michael Erdmann, Ralf Kalel, Vishal C Front Cell Dev Biol Cell and Developmental Biology Human pathogenic trypanosomatid parasites harbor a unique form of peroxisomes termed glycosomes that are essential for parasite viability. We and others previously identified and characterized the essential Trypanosoma brucei ortholog TbPEX3, which is the membrane-docking factor for the cytosolic receptor PEX19 bound to the glycosomal membrane proteins. Knockdown of TbPEX3 expression leads to mislocalization of glycosomal membrane and matrix proteins, and subsequent cell death. As an early step in glycosome biogenesis, the PEX3–PEX19 interaction is an attractive drug target. We established a high-throughput assay for TbPEX3–TbPEX19 interaction and screened a compound library for small-molecule inhibitors. Hits from the screen were further validated using an in vitro ELISA assay. We identified three compounds, which exhibit significant trypanocidal activity but show no apparent toxicity to human cells. Furthermore, we show that these compounds lead to mislocalization of glycosomal proteins, which is toxic to the trypanosomes. Moreover, NMR-based experiments indicate that the inhibitors bind to PEX3. The inhibitors interfering with glycosomal biogenesis by targeting the TbPEX3–TbPEX19 interaction serve as starting points for further optimization and anti-trypanosomal drug development. Frontiers Media S.A. 2021-12-20 /pmc/articles/PMC8721105/ /pubmed/34988071 http://dx.doi.org/10.3389/fcell.2021.737159 Text en Copyright © 2021 Li, Gaussmann, Tippler, Ott, Popowicz, Schliebs, Sattler, Erdmann and Kalel. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cell and Developmental Biology Li, Mengqiao Gaussmann, Stefan Tippler, Bettina Ott, Julia Popowicz, Grzegorz M Schliebs, Wolfgang Sattler, Michael Erdmann, Ralf Kalel, Vishal C Novel Trypanocidal Inhibitors that Block Glycosome Biogenesis by Targeting PEX3–PEX19 Interaction |
title | Novel Trypanocidal Inhibitors that Block Glycosome Biogenesis by Targeting PEX3–PEX19 Interaction |
title_full | Novel Trypanocidal Inhibitors that Block Glycosome Biogenesis by Targeting PEX3–PEX19 Interaction |
title_fullStr | Novel Trypanocidal Inhibitors that Block Glycosome Biogenesis by Targeting PEX3–PEX19 Interaction |
title_full_unstemmed | Novel Trypanocidal Inhibitors that Block Glycosome Biogenesis by Targeting PEX3–PEX19 Interaction |
title_short | Novel Trypanocidal Inhibitors that Block Glycosome Biogenesis by Targeting PEX3–PEX19 Interaction |
title_sort | novel trypanocidal inhibitors that block glycosome biogenesis by targeting pex3–pex19 interaction |
topic | Cell and Developmental Biology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721105/ https://www.ncbi.nlm.nih.gov/pubmed/34988071 http://dx.doi.org/10.3389/fcell.2021.737159 |
work_keys_str_mv | AT limengqiao noveltrypanocidalinhibitorsthatblockglycosomebiogenesisbytargetingpex3pex19interaction AT gaussmannstefan noveltrypanocidalinhibitorsthatblockglycosomebiogenesisbytargetingpex3pex19interaction AT tipplerbettina noveltrypanocidalinhibitorsthatblockglycosomebiogenesisbytargetingpex3pex19interaction AT ottjulia noveltrypanocidalinhibitorsthatblockglycosomebiogenesisbytargetingpex3pex19interaction AT popowiczgrzegorzm noveltrypanocidalinhibitorsthatblockglycosomebiogenesisbytargetingpex3pex19interaction AT schliebswolfgang noveltrypanocidalinhibitorsthatblockglycosomebiogenesisbytargetingpex3pex19interaction AT sattlermichael noveltrypanocidalinhibitorsthatblockglycosomebiogenesisbytargetingpex3pex19interaction AT erdmannralf noveltrypanocidalinhibitorsthatblockglycosomebiogenesisbytargetingpex3pex19interaction AT kalelvishalc noveltrypanocidalinhibitorsthatblockglycosomebiogenesisbytargetingpex3pex19interaction |